Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 24DAIICHI SANKYO INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 9358235

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-08

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 8461169

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-19

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10189833

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-05

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10961240

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-07-24

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10189833

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-05

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 9358235

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-08

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 8461169

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-19

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10961240

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-07-24

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 8404700

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211810

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-11-21

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10730876

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211810

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-05

blank